Central nervous system involvement in Burkitt's lymphoma.
D001932:Brain Neoplasms; D002051:Burkitt Lymphoma / Q000150:complications* / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy / Q000209:etiology*; D002555:Cerebrospinal Fluid / Q000166:cytology*; D003072:Cognition Disorders / Q000209:etiology; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007278:Injections, Spinal; D008218:Lymphocytosis / Q000209:etiology; D008727:Methotrexate / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D010264:Paraplegia / Q000209:etiology; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D005492:Folic Acid; D008727:Methotrexate